Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort)

INTRODUCTION: This planned multicenter observational study will evaluate the overall survival of those undergoing integrated Chinese and Western medicine for stage IIIb-IVb non-small cell lung cancer and analyze the factors related to the prognosis. METHOD AND ANALYSIS: The prospective cohort will e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jietao, Sun, Lingling, Chen, Hanrui, Chen, Wenmin, Zhang, Zexin, Cao, Yang, Lin, Lizhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387678/
https://www.ncbi.nlm.nih.gov/pubmed/37493017
http://dx.doi.org/10.1177/15347354231185109
_version_ 1785081936734060544
author Lin, Jietao
Sun, Lingling
Chen, Hanrui
Chen, Wenmin
Zhang, Zexin
Cao, Yang
Lin, Lizhu
author_facet Lin, Jietao
Sun, Lingling
Chen, Hanrui
Chen, Wenmin
Zhang, Zexin
Cao, Yang
Lin, Lizhu
author_sort Lin, Jietao
collection PubMed
description INTRODUCTION: This planned multicenter observational study will evaluate the overall survival of those undergoing integrated Chinese and Western medicine for stage IIIb-IVb non-small cell lung cancer and analyze the factors related to the prognosis. METHOD AND ANALYSIS: The prospective cohort will enroll patients with stage IIIb-IVb NSCLC from March 1, 2019, to December 31, 2025, and follow them for 5 years. We plan to collect data on the patients’ demographics, treatment, overall survival, and factors related to the prognosis. ETHICS AND DISSEMINATION: The institutional review board and ethics committee reviewed the study protocol. All patients will provide informed consent before enrollment. Trial registration number: ChiCTR1900021430
format Online
Article
Text
id pubmed-10387678
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-103876782023-08-01 Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort) Lin, Jietao Sun, Lingling Chen, Hanrui Chen, Wenmin Zhang, Zexin Cao, Yang Lin, Lizhu Integr Cancer Ther Study Protocol INTRODUCTION: This planned multicenter observational study will evaluate the overall survival of those undergoing integrated Chinese and Western medicine for stage IIIb-IVb non-small cell lung cancer and analyze the factors related to the prognosis. METHOD AND ANALYSIS: The prospective cohort will enroll patients with stage IIIb-IVb NSCLC from March 1, 2019, to December 31, 2025, and follow them for 5 years. We plan to collect data on the patients’ demographics, treatment, overall survival, and factors related to the prognosis. ETHICS AND DISSEMINATION: The institutional review board and ethics committee reviewed the study protocol. All patients will provide informed consent before enrollment. Trial registration number: ChiCTR1900021430 SAGE Publications 2023-07-26 /pmc/articles/PMC10387678/ /pubmed/37493017 http://dx.doi.org/10.1177/15347354231185109 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Study Protocol
Lin, Jietao
Sun, Lingling
Chen, Hanrui
Chen, Wenmin
Zhang, Zexin
Cao, Yang
Lin, Lizhu
Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort)
title Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort)
title_full Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort)
title_fullStr Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort)
title_full_unstemmed Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort)
title_short Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort)
title_sort chinese and western integrative medicine for stage iiib-ivb non-small cell lung cancer: design and rationale of a multi-center, prospective registry (nsclc-chinese and western integrative medicine cohort)
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387678/
https://www.ncbi.nlm.nih.gov/pubmed/37493017
http://dx.doi.org/10.1177/15347354231185109
work_keys_str_mv AT linjietao chineseandwesternintegrativemedicineforstageiiibivbnonsmallcelllungcancerdesignandrationaleofamulticenterprospectiveregistrynsclcchineseandwesternintegrativemedicinecohort
AT sunlingling chineseandwesternintegrativemedicineforstageiiibivbnonsmallcelllungcancerdesignandrationaleofamulticenterprospectiveregistrynsclcchineseandwesternintegrativemedicinecohort
AT chenhanrui chineseandwesternintegrativemedicineforstageiiibivbnonsmallcelllungcancerdesignandrationaleofamulticenterprospectiveregistrynsclcchineseandwesternintegrativemedicinecohort
AT chenwenmin chineseandwesternintegrativemedicineforstageiiibivbnonsmallcelllungcancerdesignandrationaleofamulticenterprospectiveregistrynsclcchineseandwesternintegrativemedicinecohort
AT zhangzexin chineseandwesternintegrativemedicineforstageiiibivbnonsmallcelllungcancerdesignandrationaleofamulticenterprospectiveregistrynsclcchineseandwesternintegrativemedicinecohort
AT caoyang chineseandwesternintegrativemedicineforstageiiibivbnonsmallcelllungcancerdesignandrationaleofamulticenterprospectiveregistrynsclcchineseandwesternintegrativemedicinecohort
AT linlizhu chineseandwesternintegrativemedicineforstageiiibivbnonsmallcelllungcancerdesignandrationaleofamulticenterprospectiveregistrynsclcchineseandwesternintegrativemedicinecohort

Ejemplares similares